中文English
ISSN 1001-5256
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

经颈静脉肝内门体分流术治疗肝硬化顽固性腹水的现状

王澜静 姚欣 秦建平 汤善宏

引用本文:
Citation:

经颈静脉肝内门体分流术治疗肝硬化顽固性腹水的现状

DOI: 10.3969/j.issn.1001-5256.2022.11.034
基金项目: 

四川省卫生健康委员会科研课题 20PJ180

利益冲突声明:所有作者均声明不存在利益冲突。
作者贡献声明:王澜静参与拟定写作思路,收集分析文献,撰写论文及修改;姚欣参与指导撰写文章及论文修改;秦建平负责拟定写作思路,指导撰写文章及论文修改;汤善宏负责指导撰写文章,论文修改及最后定稿。
详细信息
    通信作者:

    汤善宏,15928956390@163.com

TIPS for treatment of refractory ascites in cirrhosis

Research funding: 

Scientific Research Project of Sichuan Provincial Health Commission 20PJ180

More Information
  • 摘要: 顽固性腹水是肝硬化失代偿期门静脉高压的并发症之一,其治疗难度大,病死率高。目前经颈静脉肝内门体分流术(TIPS)作为顽固性腹水的二线治疗,能通过降低门静脉压力来改善腹水症状。国内外大量研究已经提出,使用覆膜TIPS支架,谨慎选择适用人群可以改善顽固性腹水患者的预后,因此有学者提出TIPS可作为顽固性腹水的一线治疗手段。本文将全面介绍国内外TIPS治疗肝硬化顽固性腹水的现状,并对相关研究进展进行阐述,旨在推动我国TIPS治疗顽固性腹水相关研究的发展。

     

  • [1] NEONG SF, ADEBAYO D, WONG F. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites[J]. Expert Rev Gastroenterol Hepatol, 2019, 13(4): 293-305. DOI: 10.1080/17474124.2018.1555469.
    [2] AITHAL GP, PALANIYAPPAN N, CHINA L, et al. Guidelines on the management of ascites in cirrhosis[J]. Gut, 2021, 70(1): 9-29. DOI: 10.1136/gutjnl-2020-321790.
    [3] LARRUE H, VINEL JP, BUREAU C. Management of severe and refractory ascites[J]. Clin Liver Dis, 2021, 25(2): 431-440. DOI: 10.1016/j.cld.2021.01.010.
    [4] MØLLER S, BENDTSEN F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis[J]. Liver Int, 2018, 38(4): 570-580. DOI: 10.1111/liv.13589.
    [5] ADEBAYO D, NEONG SF, WONG F. Refractory ascites in liver cirrhosis[J]. Am J Gastroenterol, 2019, 114(1): 40-47. DOI: 10.1038/s41395-018-0185-6.
    [6] Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of ascites and complications in cirrhosis[J]. J Clin Hepatol, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.

    中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂志, 2017, 33(10): 1847-1863. DOI: 10.3969/j.issn.1001-5256.2017.10.003.
    [7] D'AMICO G, MORABITO A, D'AMICO M, et al. Clinical states of cirrhosis and competing risks[J]. J Hepatol, 2018, 68(3): 563-576. DOI: 10.1016/j.jhep.2017.10.020.
    [8] de FRANCHIS R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63(3): 743-752. DOI: 10.1016/j.jhep.2015.05.022.
    [9] GARCÍA-PAGÁN JC, SAFFO S, MANDORFER M, et al. Where does TIPS fit in the management of patients with cirrhosis?[J]. JHEP Rep, 2020, 2(4): 100122. DOI: 10.1016/j.jhepr.2020.100122.
    [10] Chinese College of Interventionalists. CCI clinical practice guidelines: Management of TIPS for portal hypertension (2019 edition)[J]. J Clin Hepatol, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.

    中国医师协会介入医师分会. 中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2694-2699. DOI: 10.3969/j.issn.1001-5256.2019.12.010.
    [11] QIN JP, TANG W, TANG SH, et al. Modified transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension of liver cirrhosis[J]. Chin J Dig, 2014, 34(1): 33-36. DOI: 10.3760/cma.j.issn.0254-1432.2014.01.012.

    秦建平, 唐文, 汤善宏, 等. 改良经颈静脉肝内门体静脉分流术治疗肝硬化门静脉高压症[J]. 中华消化杂志, 2014, 34(1): 33-36. DOI: 10.3760/cma.j.issn.0254-1432.2014.01.012.
    [12] TANG SH, QIN JP, SHU QF, et al. The imaging guidance for the portal vein branch puncturing in performing TIPS: recent progress in research[J]. J Intervent Radiol, 2014, 23(7): 640-643. DOI: 10.3969/j.issn.1008-794X.2014.07.022.

    汤善宏, 秦建平, 束庆飞, 等. TIPS术中引导门静脉分支穿刺方法[J]. 介入放射学杂志, 2014, 23(7): 640-643. DOI: 10.3969/j.issn.1008-794X.2014.07.022.
    [13] BIGGINS SW, ANGELI P, GARCIA-TSAO G, et al. Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases[J]. Hepatology, 2021, 74(2): 1014-1048. DOI: 10.1002/hep.31884.
    [14] ARROYO V, GINÈS P, GERBES AL, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club[J]. Hepatology, 1996, 23(1): 164-176. DOI: 10.1002/hep.510230122.
    [15] SUN MY, TANG SH, ZENG WZ. An excerpt of 2017 KASL clinical practice guidelines for fiver cirrhosis: Ascites and related complications[J]. J Clin Hepatol, 2018, 34(9): 1877-1878. DOI: 10.3969/j.issn.1001-5256.2018.09.010.

    孙梦滢, 汤善宏, 曾维政. 《2017年韩国肝病学会临床实践指南: 肝硬化-腹水及相关并发症》摘译[J]. 临床肝胆病杂志, 2018, 34(9): 1877-1878. DOI: 10.3969/j.issn.1001-5256.2018.09.010.
    [16] FUKUI H, SAITO H, UENO Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015[J]. J Gastroenterol, 2016, 51(7): 629-650. DOI: 10.1007/s00535-016-1216-y.
    [17] ZHANG X, WANG SZ, ZHENG JF, et al. Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients[J]. World J Gastroenterol, 2014, 20(32): 11400-11405. DOI: 10.3748/wjg.v20.i32.11400.
    [18] BOIKE JR, THORNBURG BG, ASRANI SK, et al. North American practice-based recommendations for transjugular intrahepatic portosystemic shunts in portal hypertension[J]. Clin Gastroenterol Hepatol, 2022, 20(8): 1636-1662. DOI: 10.1016/j.cgh.2021.07.018.
    [19] de FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno VⅡ-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
    [20] BOSCH J. Small diameter shunts should lead to safe expansion of the use of TIPS[J]. J Hepatol, 2021, 74(1): 230-234. DOI: 10.1016/j.jhep.2020.09.018.
    [21] BUREAU C, THABUT D, OBERTI F, et al. Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites[J]. Gastroenterology, 2017, 152(1): 157-163. DOI: 10.1053/j.gastro.2016.09.016.
    [22] TAN HK, JAMES PD, SNIDERMAN KW, et al. Long-term clinical outcome of patients with cirrhosis and refractory ascites treated with transjugular intrahepatic portosystemic shunt insertion[J]. J Gastroenterol Hepatol, 2015, 30(2): 389-395. DOI: 10.1111/jgh.12725.
    [23] PARVINIAN A, BUI JT, KNUTTINEN MG, et al. Transjugular intrahepatic portosystemic shunt for the treatment of medically refractory ascites[J]. Diagn Interv Radiol, 2014, 20(1): 58-64. DOI: 10.5152/dir.2013.13131.
    [24] SALERNO F, CAMMÀ C, ENEA M, et al. Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data[J]. Gastroenterology, 2007, 133(3): 825-834. DOI: 10.1053/j.gastro.2007.06.020.
    [25] SRINIVASA RN, SRINIVASA RN, CHICK J, et al. Transjugular intrahepatic portosystemic shunt reduction using the GORE VIATORR controlled expansion endoprosthesis: Hemodynamics of reducing an established 10-mm TIPS to 8-mm in diameter[J]. Cardiovasc Intervent Radiol, 2018, 41(3): 518-521. DOI: 10.1007/s00270-017-1807-x.
    [26] MIRAGLIA R, MARUZZELLI L, DI PIAZZA A, et al. Transjugular intrahepatic portosystemic shunt using the new gore viatorr controlled expansion endoprosthesis: Prospective, single-center, preliminary experience[J]. Cardiovasc Intervent Radiol, 2019, 42(1): 78-86. DOI: 10.1007/s00270-018-2040-y.
    [27] TREBICKA J, BASTGEN D, BYRTUS J, et al. Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival[J]. Clin Gastroenterol Hepatol, 2019, 17(13): 2793-2799. e1. DOI: 10.1016/j.cgh.2019.03.042.
    [28] PIEPER CC, JANSEN C, MEYER C, et al. Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts-A three-dimensional sonography study[J]. J Vasc Interv Radiol, 2017, 28(1): 117-125. DOI: 10.1016/j.jvir.2016.06.023.
    [29] European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis[J]. J Hepatol, 2018, 69(2): 406-460. DOI: 10.1016/j.jhep.2018.03.024.
    [30] SCHEPIS F, VIZZUTTI F, GARCIA-TSAO G, et al. Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis[J]. Clin Gastroenterol Hepatol, 2018, 16(7): 1153-1162. e7. DOI: 10.1016/j.cgh.2018.01.029.
    [31] BAI M, QI XS, YANG ZP, et al. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis[J]. World J Gastroenterol, 2014, 20(10): 2704-2714. DOI: 10.3748/wjg.v20.i10.2704.
    [32] BUCSICS T, HOFFMAN S, GRVNBERGER J, et al. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis[J]. Liver Int, 2018, 38(6): 1036-1044. DOI: 10.1111/liv.13615.
    [33] SHEN NT, SCHNEIDER Y, CONGLY SE, et al. Cost effectiveness of early insertion of transjugular intrahepatic portosystemic shunts for recurrent ascites[J]. Clin Gastroenterol Hepatol, 2018, 16(9): 1503-1510. e3. DOI: 10.1016/j.cgh.2018.03.027.
    [34] POSE E, CARDENAS A. Translating our current understanding of ascites management into new therapies for patients with cirrhosis and fluid retention[J]. Dig Dis, 2017, 35(4): 402-410. DOI: 10.1159/000456595.
    [35] ALLEGRETTI AS, ORTIZ G, CUI J, et al. Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: A matched cohort analysis[J]. Am J Kidney Dis, 2016, 68(3): 381-391. DOI: 10.1053/j.ajkd.2016.02.041.
    [36] YAO X, ZHOU H, HUANG S, et al. Effects of transjugular intrahepatic portosystemic shunt using the Viatorr stent on hepatic reserve function in patients with cirrhosis[J]. World J Clin Cases, 2021, 9(7): 1532-1542. DOI: 10.12998/wjcc.v9.i7.1532.
    [37] QIN JP, TANG SH, JIANG MD, et al. Contrast enhanced computed tomography and reconstruction of hepatic vascular system for transjugular intrahepatic portal systemic shunt puncture path planning[J]. World J Gastroenterol, 2015, 21(32): 9623-9629. DOI: 10.3748/wjg.v21.i32.9623.
  • 加载中
计量
  • 文章访问数:  106
  • HTML全文浏览量:  28
  • PDF下载量:  37
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-03-22
  • 录用日期:  2022-05-07
  • 出版日期:  2022-11-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回